On Sunday, April 20th 2025, starting 8:30am GMT, there will be maintenance work that will involve the website being unavailable during parts of the day. We apologize for any inconvenience this may cause and appreciate your understanding.
We noted you are experiencing viewing problems
-
Check with your IT department that JWPlatform, JWPlayer and Amazon AWS & CloudFront are not being blocked by your network. The relevant domains are *.jwplatform.com, *.jwpsrv.com, *.jwpcdn.com, jwpltx.com, jwpsrv.a.ssl.fastly.net, *.amazonaws.com and *.cloudfront.net. The relevant ports are 80 and 443.
-
Check the following talk links to see which ones work correctly:
Auto Mode
HTTP Progressive Download Send us your results from the above test links at access@hstalks.com and we will contact you with further advice on troubleshooting your viewing problems. -
No luck yet? More tips for troubleshooting viewing issues
-
Contact HST Support access@hstalks.com
-
Please review our troubleshooting guide for tips and advice on resolving your viewing problems.
-
For additional help, please don't hesitate to contact HST support access@hstalks.com
We hope you have enjoyed this limited-length demo
This is a limited length demo talk; you may
login or
review methods of
obtaining more access.
Printable Handouts
Navigable Slide Index
- Introduction
- Cancer-centric view
- Issues with the cancer-centric view
- THE CANCER IS SURROUNDED BY THE PATIENT
- The cancer patient
- Tumor Organismal Environment (TOE)
- Overview of the Tumor Microenvironment (TME)
- Plants and their immediate environment
- Differential effects of ECM proteins on actin and focal adhesions
- ECM proteins impact lung metastasis formation
- The in vivo environment accelerates tumorigenesis
- The Tumor Microenvironment (TME)
- Principles of intra-TME interactions
- Heraclitus
- Bidirectional crosstalk
- Principles of intra-TME interactions: Tumor progression
- Tumor progression and regression
- Tumor dormancy
- Principles of intra-TME interactions: Pro- or anti-malignancy functions
- Principles of intra-TME interactions: Hijacking physiological elements
- Tumor cells hijack physiological elements
- Principles of intra-TME interactions: Different tumor microenvironments
- Metastasis kills
- Site-specific metastasis
- Early observations on site-specific metastasis
- Stephen Paget
- The TME shapes the phenotype of the tumor
- The pre-metastatic niche
- Formation of the pre-metastatic niche
- Tumor-derived extracellular vesicles (EVs) and the pre-metastatic organ
- The metastatic cascade (1)
- Regulation of the metastatic cascade
- Epithelial to Mesenchymal Transition (EMT)
- The TME regulates the EMT
- The metastatic cascade (2)
- Intravasation
- Circulating cancer cells interact with platelets
- The role of platelets
- Extravasation
- Extravasation steps of cancer cells
- Selectins and tumor cell rolling
- The functional role of integrins in extravasation
- Integrins involved in the firm adhesion of tumor cells to the endothelium
- Chemokine receptor-mediated migration
- Targeted migration of chemokine receptor-expressing cancer cells
- The fate of tumor cells at metastatic organ sites
- Metastatic-promoting and metastatic-restraining factors
- Metastasis-restraining signals
- The short peptide of human HBB (Metox) inhibits tumor growth
- Metox inhibits neuroblastoma metastasis
- Interactions between tumors and their microenvironment
- Targeting tumor-TME interactions
- 2018 Nobel Prize laureates James Allison & Tasuku Honjo
- Immune checkpoint blocking enables TME-infiltrating T cells to kill tumor cells
- A history of exploring cancer in context
- A rephrased statement of Stephen Paget (IPW)
- Witz Team 2020-2021
- My sincere thanks
Topics Covered
- Tumor Organismal Environment (TOE) and Tumor Microenvironment (TME)
- Principles of intra-TME interactions
- Tumor progression and regression
- Site-specific metastasis
- The pre-metastatic niche
- The metastatic cascade
- Epithelial to Mesenchymal Transition (EMT)
- Targeting tumor-TME interactions
- Immune checkpoint blocking enables TME-infiltrating T cells to kill tumor cells
Links
Series:
Categories:
Therapeutic Areas:
Talk Citation
Witz, I.P. (2021, March 31). How tumor-microenvironment interactions drive or inhibit metastasis [Video file]. In The Biomedical & Life Sciences Collection, Henry Stewart Talks. Retrieved April 15, 2025, from https://doi.org/10.69645/TCZM2907.Export Citation (RIS)
Publication History
- Published on March 31, 2021
Financial Disclosures
- Prof. Isaac P. Witz has not informed HSTalks of any commercial/financial relationship that it is appropriate to disclose.
Other Talks in the Series: Periodic Reports: Advances in Clinical Interventions and Research Platforms
Transcript
Please wait while the transcript is being prepared...
0:00
Hello, I'm Professor Isaac Witz,
head of the tumor microenvironment and metastasis research lab at
the Shmunis School of Biomedicine & Cancer Research at Tel Aviv University.
I am going to talk to you about the role of
the microenvironment in the progression of tumor cells towards metastasis.
The tumor microenvironment has become a very extensive research area.
Any single topic touched upon in this presentation would require a separate lecture.
Today's lecture will therefore only be an overview of this multi-disciplinary field.
0:38
To start, let me take you back to the 70s and 80s of the last century.
The cancer research field at that time,
was dominated by the concept that oncogenes and
tumor-suppressor genes are the only and exclusive causes of cancer.
Let me read you one sentence from a paper published in '83 by Michael Bishop,
who together with Harold Varmus was awarded the Nobel Prize for the discovery of oncogenes:
"A common set of cellular genes may help to mediate
the genesis of all tumors, whatever their cause".
Please judge for yourself to what extent you agree with this statement.
1:25
The cancer-centric view did not provide
a satisfactory mechanism for the progression towards metastasis.
Two leading cancer geneticists,
the late Ruth Sager and Bert Vogelstein, raised this important issue.